Greenway Nicola Deidre Petal's Form 4 filing
Takeda Pharmaceutical Co Ltd (TAK) · filed Aug 12, 2026
- Accession no.
- 0001493152-26-037351
- Filed
- Aug 12, 2026, 4:10 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $605.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Greenway Nicola Deidre PetalCIK 0002123546 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | American Depositary Shares | SSaleDisposed | −975 | $17.50 | −$17,062.5 | 93,431 | Direct | |
| Aug 10, 2026 | American Depositary Shares | SSaleDisposed | −33,628 | $17.51 | −$588,715.31 | 59,803 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.